(XERS) Xeris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xeris Pharmaceuticals | (XERS) share price targets
Complete technical analysis of Xeris Pharmaceuticals (XERS) by charts plus indicators, forecast predictions and share price targets for Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-21 View latest technical analysis
10 day averaged volume of Xeris Pharmaceuticals is 985910
Date | Daily Closing Price | Open | High | Low | Volume |
21 Mon Oct 2024 | 3.03 | 3.04 | 3.09 | 2.98 | 1.071 times |
18 Fri Oct 2024 | 3.06 | 3.04 | 3.12 | 3.03 | 0.95 times |
17 Thu Oct 2024 | 3.04 | 3.04 | 3.06 | 2.97 | 0.662 times |
16 Wed Oct 2024 | 3.04 | 3.05 | 3.11 | 3.00 | 1.219 times |
15 Tue Oct 2024 | 3.02 | 2.97 | 3.05 | 2.90 | 1.176 times |
14 Mon Oct 2024 | 2.97 | 2.89 | 2.99 | 2.86 | 0.762 times |
11 Fri Oct 2024 | 2.91 | 2.78 | 2.92 | 2.78 | 0.979 times |
10 Thu Oct 2024 | 2.78 | 2.77 | 2.79 | 2.73 | 0.977 times |
09 Wed Oct 2024 | 2.81 | 2.93 | 2.95 | 2.75 | 1.518 times |
08 Tue Oct 2024 | 2.94 | 2.91 | 3.00 | 2.85 | 0.739 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 3, but if it comes below 3, then a intra day sell could be more profitable.
If you take a sell trade below 3, then use 3 as stoploss and 2.92 as target. However if you take a buy trade in stock , then use 3 as stoploss and 3.1 as target.
Share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Target | 2.03 |
Downside Target | 2.48 |
Downside Target | 2.67 |
Downside Target | 2.86 |
Downside Target | 2.94 |
Downside Target | 2.98 |
Downside Target | 3.02 |
Upside Target | 3.04 |
Upside Target | 3.05 |
Upside Target | 3.09 |
Upside Target | 3.12 |
Intraday share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Intraday Target | 2.98 |
Downside Intraday Target | 2.92 |
Upside Intraday Target | 3.09 |
Upside Intraday Target | 3.14 |
Upside Intraday Target | 3.03 |
Weekly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Weekly Closing Price | Open | High | Low | Volume |
21 Mon Oct 2024 | 3.03 | 3.04 | 3.09 | 2.98 | 0.225 times |
18 Fri Oct 2024 | 3.06 | 2.89 | 3.12 | 2.86 | 0.911 times |
11 Fri Oct 2024 | 2.91 | 2.99 | 3.02 | 2.73 | 0.766 times |
04 Fri Oct 2024 | 2.98 | 2.88 | 3.05 | 2.69 | 1.107 times |
27 Fri Sep 2024 | 2.87 | 2.95 | 2.95 | 2.71 | 0.619 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Monthly Closing Price | Open | High | Low | Volume |
21 Mon Oct 2024 | 3.03 | 2.85 | 3.12 | 2.69 | 0.458 times |
30 Mon Sep 2024 | 2.85 | 2.79 | 3.04 | 2.48 | 1.008 times |
30 Fri Aug 2024 | 2.81 | 2.49 | 2.94 | 2.10 | 1.384 times |
31 Wed Jul 2024 | 2.48 | 2.24 | 2.67 | 2.03 | 0.955 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xeris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.95 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xeris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.95 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.